Skip to content

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing

Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing GENEPIC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03065686
Acronym
GENEPIC
Enrollment
30
Registered
2017-02-28
Start date
2016-11-30
Completion date
2027-11-30
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Lip and Palate

Keywords

Cleft Lip and Palate, CL/P, WES

Brief summary

Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting

Detailed description

Despite significant progress made in identification on numerous genes and gene pathways critical for craniofacial development, several approaches, ie mutation screening of specific candidates, association studies and even genome-wide scans have largely failed to reveal the molecular basis of NS human clefting. Moreover, the efficiency of Whole Exome Sequencing -WES- was proven. The efficiency of WES was proven by the identification of the genes causing Freeman Sheldon and Miller's syndrome, followed by several others. In the Picardy region, management and follow-up of orofacial cleft patients are well-organised by a multidisciplinary team in the university hospital of Amiens. The investigators therefore decided to perform whole exome sequencing (WES) on precisely phenotyped non-syndromic CL/P patients followed in our center.

Interventions

GENETICidentification of genetic factors

Clinical questionnaire and analysis of genetic data obtained by exome high-throughput sequencing

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject with a NSCL/P or CL/P of unknown etiology, * national health care insurance holders

Exclusion criteria

* Subject with a CL/P of known etiology, * Subject with a NSCL/P and an IRF6 mutation

Design outcomes

Primary

MeasureTime frameDescription
Identification of genetic factorsDay 1Identification of genetic factors implicated in orofacial cleft using whole exome sequencing (WES).

Countries

France

Contacts

CONTACTBénédicte DEMEER, MD
demeer.benedicte@chu-amiens.fr+33 3 22 08 75 81
PRINCIPAL_INVESTIGATORBénédicte DEMEER, MD

CHU Amiens

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026